Foto del docente

Laura Rullo

Fixed-term Researcher in Tenure Track L. 79/2022

Department of Pharmacy and Biotechnology

Academic discipline: BIOS-11/A Pharmacology

Curriculum vitae

PROFESSIONAL EXPERIENCES

Oct 2024 – Present: Tenure Track Researcher (RTT), Department of Pharmacy and Biotechnology, University of Bologna.

Jan 2021 – Sept 2024: Research Fellow, Molecular Neuropharmacology Laboratory, University of Bologna.

Jul 2022 – Dec 2022: External Postdoctoral Researcher, Department of Molecular Medicine, UF-Scripps Biomedical Campus, Jupiter (FL, USA).

Nov 2017 – Dec 2020: PhD Student, Molecular Neuropharmacology Laboratory, University of Bologna.

Jan 2020 – Jul 2020: External Graduate Student, Scripps Research Institute, Jupiter (FL, USA).

Oct 2016 – Oct 2017: Research Trainee, Molecular Neuropharmacology Laboratory, University of Bologna.

Sept 2014 – Oct 2015: Master’s Thesis Student, Molecular Neuropharmacology Laboratory, University of Bologna.

EDUCATION

PhD in Biotechnological, Biocomputational, Pharmaceutical and Pharmacological Sciences (May 2021), University of Bologna.

Master’s Degree in Pharmaceutical Chemistry and Technology (CTF) (Oct 2015, score 108/110), University of Bologna. Experimental thesis: “Gene expression alterations of opioid receptors MOP and NOP following exposure to Withania somnifera and Naloxone in vitro”.

Scientific High School Diploma (2009, score 100/100), Liceo Scientifico C. Pisacane, Centola (SA).

AWARDS and FELLOWSHIPS

Marco Polo Fellowship (2022, 2019) – Visiting researcher at UF-Scripps Biomedical Campus and Scripps Research Institute (FL, USA).

SIF Fellowship for Short Research Periods Abroad (2022, 2020) – Visiting researcher at UF-Scripps Biomedical Campus and Scripps Research Institute (FL, USA).

Best Oral Presentation Award (2019) – 1st International Conference Perinatal Origins of Neuropsychiatric Disorders, Palermo, Italy.

Best Master’s Thesis Award (2017) – Department of Pharmacy and Biotechnology, University of Bologna.

 

Latest news

At the moment no news are available.